<DOC>
<DOCNO>
EP-0002777
</DOCNO>
<TEXT>
<DATE>
19790711
</DATE>
<IPC-CLASSIFICATIONS>
A61K-9/00 A61K-49/00 A61K-9/107 A61K-38/22 
</IPC-CLASSIFICATIONS>
<TITLE>
stable secretin composition, process for its preparation and its use.
</TITLE>
<APPLICANT>
hoechst agde<sep>hoechst aktiengesellschaft<sep>hoechst aktiengesellschaft65926 frankfurt am mainde<sep>
</APPLICANT>
<INVENTOR>
bickel martin drde <sep>koenig wolfgang drde  <sep>leeb richard drde<sep>bickel, martin, dr.<sep>koenig, wolfgang, dr.<sep>leeb, richard, dr.<sep>bickel, martin, dr.breitlacherstrasse 25d-6000 frankfurt/main 90de<sep>k√∂nig, wolfgang, dr.eppsteiner strasse 25d-6238 hofheim am taunusde<sep>leeb, richard, dr.nonnbornstrasse 15d-6233 kelkheim (taunus)de<sep>
</INVENTOR>
<ABSTRACT>
the stable secretin composition has a ph of 3. 0 and is used for the treatment of acute gastric haemorrhages, duodenal ulcer, gastric ulcer, zollinger-ellison syndrome, mucoviscidosis and reflux oesophagitis, for the prophylaxis of stress ulcers and for the diagnosis of pancreatic function and of duodenal ulcer.  the activity maximum is at ph 3 as shown in figure 1.  <image>
</ABSTRACT>
</TEXT>
</DOC>
